Brain metastases

Handbook of Clinical Neurology

Volumn 105, Issue , 2012, Pages 747-755

  Soffietti, R ^a   Ducati, A ^a   Ruda R ^a  

^a MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84855557072     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-53502-3.00021-5     Document Type: Chapter

References (74)

1. Agboola O., Benoit B., Cross P., et al. Prognostic factors derived from recursive partition analysis (RPA) of Radiation Therapy Oncology Group (RTOG) brain metastases trials applied to surgically resected and irradiated brain metastatic cases. Int J Radiat Oncol Biol Phys 1998, 42:155-159.
2. Andrews D.W., Scott C.B., Sperduto P.W., et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG randomised trial. Lancet 2004, 363:1665-1672.
3. Antonadou D., Paraskevaidis M., Sarris G., et al. Phase 2 randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases. J Clin Oncol 2002, 20:3644-3650.
4. Aoyama H., Shirato H., Tago M., et al. Stereotactic radiosurgery plus wholebrain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006, 295:2483-2491.
5. Aoyama H., Tago M., Kato N., et al. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 2007, 68:1388-1395.
6. Baumert B.G., Rutten I., Dehing-Oberije C., et al. A pathology-based substrate for target definition in radiosurgery of brain metastases. Int J Radiat Oncol Biol Phys 2006, 66:187-194.
7. Borgelt B., Gelber R.D., Kramer S., et al. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1980, 6:1-9.
8. Bouffet E., Doumi N., Thiesse P., et al. Brain metastases in children with solid tumors. Cancer 1997, 79:403-410.
9. Byrne T.N., Cascino T.L., Posner J.B. Brain metastasis from melanoma. J Neurooncol 1983, 1:313-317.
10. Cairncross J.G., Posner J.B. The management of brain metastases. Oncology of the Nervous System 1983, 342-377. Martinus Nijhoff, Boston. M.D. Walker (Ed.).
11. Ceresoli G., Cappuzzo F., Gregorc V., et al. Gefitinib in patients with brain metastases from non-small cell lung cancer: a prospective trial. Ann Oncol 2004, 15:1042-1047.
12. Chao S.T., Suh J.H., Raja S., et al. The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery. Int J Cancer 2001, 96:191-197.
13. Chidel M.A., Suh J.H., Reddy C.A., et al. Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases. Int J Radiat Oncol Biol Phys 2000, 47:993-999.
14. De Angelis L.M., Delattre J.Y., Posner J.B. Radiation-induced dementia in patients cured of brain metastases. Neurology 1989, 39:789-796.
15. De la Monte M.S., Moore G.W., Hutchins G.M. Pattern of distribution of metastases from malignant melanoma in humans. Cancer Res 1983, 43:3427-3433.
16. Delattre J.Y., Krol G., Thaler H.T., et al. Distribution of brain metastases. Arch Neurol 1988, 45:741-744.
17. Desprechins B., Stadnik T., Koerts G., et al. Use of diffusion-weighted MR imaging in the differential diagnosis between intracerebral necrotic tumors and cerebral abscesses. AJNR Am J Neuroradiol 1999, 20:1252-1257.
18. Ewend M.G., Brem S., Gilbert M., et al. Treatment of single brain metastasis with resection, intracavity carmustine polymer wafers, and radiation therapy is safe and provides excellent local control. Clin Cancer Res 2007, 13:3637-3641.
19. Fekrazad M.H., Ravindranathan M., Jones D.V. Response of intracranial metastases to erlotinib therapy. J Clin Oncol 2007, 25:5024-5026.
20. Fidler I.J., Yano S., Zhang R.D., et al. The seed and soil hypothesis: vascularisation and brain metastases. Lancet Oncol 2002, 3:53-57.
21. Fuentes S., Delsanti C., Metellus P., et al. Brainstem metastases: management using gamma knife radiosurgery. Neurosurgery 2006, 58:37-42.
22. Gaspar L.E., Scott C., Murray K., et al. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 2000, 47:1001-1006.
23. Gaspar L., Scott C., Rotman M., et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997, 37:745-751.
24. Glantz M.J., Cole B.F., Forsyth P.A., et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000, 54:1886-1893.
25. Gould M.K., Dembitzer A.D., Doyle R.L., et al. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials. Ann Intern Med 1999, 130:800-809.
26. Gutiérrez A.N., Westerly D.C., Tome W.A., et al. Whole brain radiotherapy with hippocampal avoidance and simultaneously integrated brain metastases boost: a planning study. Int J Radiat Oncol Biol Phys 2007, 69:589-597.
27. Hartmann M., Jansen O., Heiland S., et al. Restricted diffusion within ring enhancement is not pathognomonic for brain abscess. AJNR Am J Neuroradiol 2001, 22:1738-1742.
28. Hoskin P.J., Brada M. Radiotherapy for brain metastases. Clin Oncol 2001, 13:91-94.
29. Kelly K., Bunn P.A. It is time to reevaluate our approach to the treatment of brain metastases in patients with non-small cell lung cancer?. Lung Cancer 1998, 20:85-91.
30. Klee B., Law I., Hoigaard L., et al. Detection of unknown primary tumors in patients with cerebral metastases using whole-body 18F-fluorodeoxyglucose positron emission tomography. Eur J Neurol 2002, 9:657-662.
31. Lagerwaard F.L., Jevendag P.J., Nowak P.J., et al. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 1999, 43:795-803.
32. Le Chevalier T., Smith F.P., Caille P., et al. Site of primary malignancies in patients presenting with cerebral metastases: a review of 120 cases. Cancer 1985, 56:880-882.
33. Lee A.Y., Levine M.N., Baker R.I., et al. Low-molecular-weight heparin versus coumarin for the prevention of recurrent venous thromboembolism in cancer. N Engl J Med 2003, 349:146-153.
34. Lin N.U., Diéras V., Paul D., et al. Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer. Clin Cancer Res 2009, 15:1452-1459.
35. Manon R., O'Neill A., Knisely J., et al. Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an Eastern Cooperative Oncology Group study (E 6397). J Clin Oncol 2005, 23:8870-8876.
36. Mehta M.P., Tsao M.N., Whelan T.J., et al. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 2005, 63:37-46.
37. Mehta M.P., Shapiro W.R., Phan S.C., et al. Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial. Int J Radiat Oncol Biol Phys 2009, 73:1069-1076.
38. Merchut M.P. Brain metastases from undiagnosed systemic neoplasms. Arch Intern Med 1989, 149:1076-1080.
39. Mintz A.H., Kestle J., Rathbone M.P., et al. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 1996, 78:1470-1476.
40. Monje M.L., Palmer T. Radiation injury and neurogenesis. Curr Opin Neurol 2003, 16:129-134.
41. Muller R.P., Soffietti R., Abacioglu M.U., et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of 1-3 cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol 2009, 27:89s.
42. Nguyen L.N., Maor M.H., Oswald M.J. Brain metastases as the only manifestation of an undetected primary tumor. Cancer 1998, 83:2181-2184.
43. Nicolson G.L., Menter G.D., Herrmann J.L., et al. Brain metastasis: role of trophic, autocrine, and paracrine factors in tumor invasion and colonization of the central nervous system. Curr Top Microbiol Immunol 1996, 213:89-115.
44. Patchell R.A., Tibbs P.A., Walsh J.W., et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990, 322:494-500.
45. Patchell R.A., Tibbs P.A., Regine W.F., et al. Postoperative radiotherapy in the treatment of single brain metastases to the brain. JAMA 1998, 280:1485-1489.
46. Pollock B.E., Brown P.D., Foote R.L., et al. Properly selected patients with multiple brain metastases may benefit from aggressive treatment of their intracranial disease. J Neurooncol 2003, 61:73-80.
47. Rades D., Kueter J.D., Veninga T., et al. Whole brain radiotherapy plus stereotactic radiosurgery (WBRT+SRS) versus surgery plus whole brain radiotherapy (OP + WBRT) for 1-3 brain metastases: results of a matched pair analysis. Eur J Cancer 2009, 45:400-404.
48. Regine W.F., Huhn J.L., Patchell R.A., et al. Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: results and implications. Int J Radiat Oncol Biol Phys 2002, 52:333-338.
49. Rock J.P., Scarpace L., Hearshen D., et al. Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and image-guided histopathology with special attention to radiation necrosis. Neurosurgery 2004, 54:1111-1117.
50. Rogers L.R., Rock J.P., Sills A.K., et al. Results of a phase II trial of the GliaSite Radiation Therapy System for treatment of newly diagnosed, resected single brain metastases. J Neurosurg 2006, 105:375-384.
51. Rudà R., Borgognone M., Benech F., et al. Brain metastases from unknown primary tumor A prospective study. J Neurol 2001, 248:394-398.
52. Sawrie S.M., Guthrie B.L., Spencer S.A., et al. Predictors of distant brain recurrence for patients with newly diagnosed brain metastases treated with stereotactic radiosurgery alone. Int J Radiat Oncol Biol Phys 2007, 70:181-186.
53. Schellinger P.D., Meinck H.M., Thron A. Diagnostic accuracy of MRI compared to CT in patients with brain metastases. J Neurooncol 1999, 44:275-281.
54. Scott C., Suh J., Stea B., et al. Improved survival, quality of life, and quality-adjusted survival in breast cancer patients treated with efaproxiral (Efaproxyn) plus whole-brain radiation therapy for brain metastases. Am J Clin Oncol 2007, 30:580-587.
55. Shaw E., Scott C., Souhami L., et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 2000, 47:291-298.
56. Shimato S., Mitsudomi T., Kosaka T., et al. EGFR mutations in patients with brain metastases from lung cancer: association with the efficacy of gefitinib. Neuro-oncol 2006, 8:137-144.
57. Sneed P.K., Suh J.H., Goetsch S.J., et al. A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 2002, 53:519-526.
58. Soffietti R., Rudà R., Mutani R. Management of brain metastases. J Neurol 2002, 249:1357-1369.
59. Soffietti R., Costanza A., Laguzzi E., et al. Radiotherapy and chemotherapy of brain metastases. J Neurooncol 2005, 75:1-12.
60. Soffietti R., Rudà R., Trevisan E. Brain metastases: current management and new developments. Curr Opin Oncol 2008, 20:676-684.
61. Soltys S.G., Adlwer J.R., Lipani J.D., et al. Stereotactic radiosurgery of the postoperative resection cavity for brain metastases. Int J Radiat Oncol Biol Phys 2007, 70:187-193.
62. Sperduto P.W., Berkey B., Gaspar L.E., et al. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 2008, 70:510-514.
63. Suki D., Abouassi H., Patel A.J., et al. Comparative risk of leptomeningeal disease after resection or stereotactic radiosurgery for solid tumor metastasis to the posterior fossa. J Neurosurg 2008, 108:248-257.
64. Sze G., Milano E., Johnson C., et al. Detection of brain metastases: comparison of contrast-enhanced MR with unenhanced MR and enhanced CT. AJNR Am J Neuroradiol 1990, 11:785-791.
65. Sze G., Johnson C., Kawamura Y., et al. Comparison of single- and triple-dose contrast material in the MR screening of brain metastases. AJNR Am J Neuroradiol 1998, 19:821-828.
66. Van de Pol M., van Aalst V.C., Wilmink J.T., et al. Brain metastases from an unknown primary tumor: which diagnostic procedures are indicated?. J Neurol Neurosurg Psychiatry 1996, 61:321-323.
67. Vecht C.J., Haaxma-Reiche H., Noordijk E.M., et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?. Ann Neurol 1993, 33:583-590.
68. Vecht C.J., Hovestadt A., Verbiest H.B., et al. Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per day. Neurology 1996, 44:675-680.
69. Verger E., Gil M., Yaya R., et al. Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase 2 trial. Int J Radiat Oncol Biol Phys 2005, 61:185-191.
70. Vogelbaum M.A., Suh J.H. Resectable brain metastases. J Clin Oncol 2006, 24:1289-1294.
71. Weltman E., Salvajoli J.V., Brandt R.A., et al. Radiosurgery for brain metastases: a score index for predicting prognosis. Int J Radiat Oncol Biol Phys 2000, 46:1155-1161.
72. Williams B.J., Suki D., Fox B.D., et al. Stereotactic radiosurgery for metastatic brain tumors: a comprehensive review of complications. J Neurosurg 2009, 111:439-448.
73. Yano S., Shinohara H., Herbst R.S., et al. Expression of vascular endothelial growth factor is necessary but not sufficient for production and growth of brain metastasis. Cancer Res 2000, 60:4959-4967.
74. Yuh W.T., Tali E.T., Nguyen H., et al. The effect of contrast dose, imaging time, and lesion size in the MR detection of intracerebral metastasis. AJNR Am J Neuroradiol 1995, 16:373-380.